Trademark: 97661045
Word
YURZEF
Status Date
Tuesday, May 7, 2024
Filing Date
Thursday, November 3, 2022
Published for Opposition
Tuesday, October 10, 2023
5 Pharmaceutical preparations for the treatment of COVID 19, coronaviruses, and respiratory and infectious diseases; Pharmaceuticals, namely, prodrugs, protein fusion compounds and inhibitors for the treatment of COVID-19, coronaviruses, and respiratory and infectious diseases; Antiviral prodrugs
Nov 21, 2022
New Application Office Supplied Data Entered
Nov 7, 2022
New Application Entered
Aug 17, 2023
Assigned To Examiner
Sep 1, 2023
Approved For Pub - Principal Register
Sep 20, 2023
Notification Of Notice Of Publication E-Mailed
Oct 10, 2023
Published For Opposition
Oct 10, 2023
Official Gazette Publication Confirmation E-Mailed
May 7, 2024
Sou Extension 1 Granted
May 7, 2024
Sou Teas Extension Received
May 7, 2024
Sou Extension 1 Filed
May 8, 2024
Notice Of Approval Of Extension Request E-Mailed
Apr 24, 2024
Automatic Update Of Assignment Of Ownership
Dec 5, 2023
Noa E-Mailed - Sou Required From Applicant
Trademark Alertz updated from USPTO on 2030-01-24